StataDX is building the world's first point-of-care diagnostics platform for Neurology.

StataDx

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies.  The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about the composition of a system in real-time. Stata DX was established in Cambridge, Massachusetts.

Health Care Companies

Medical Organizations

Biotechnology Companies

MassVentures

Cambridge

City in Middlesex County, Massachusetts, United States of America

United States of America

Country primarily located in North America

Greater Boston

Metropolitan area in Massachusetts, New Hampshire and Rhode Island, USA

Massachusetts

Middlesex County

Nursing and Residential Care Facilities

Health Care and Social Assistance

Research and Development in Biotechnology (except Nanobiotechnology)

Research and Development in the Physical, Engineering, and Life Sciences

Scientific Research and Development Services

Professional, Scientific, and Technical Services

Health Care and Social Assistance, Health

Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Offices And Clinics Of Other Health Practitioners

Health Services

Commercial Physical And Biological Research

Research, Development, And Testing Services

Engineering, Accounting, Research, Management, And Related Services

Polyfill

web-vitals

Sectigo

React

Google Cloud Platform

sentry

lodash

StataDx Funding & Investors

Total Amount Raised: $2,700,000

StataDx Funding Rounds

Seed Investors

💸 Investors

📚 Popular Blog Posts